Unknown

Dataset Information

0

Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.


ABSTRACT: Five years ago, we highlighted Canada's emerging problem of prescription opioid (PO)-related harms and emphasized the need for targeted surveillance, research and interventions. Overall levels of PO use in the Canadian population have grown by 70% since then, while at the same time levels of non-medical PO use (NMPOU) in general and in key risk populations have continued to be high; furthermore, PO-related harms - specifically morbidity (e.g., treatment admissions) and mortality (e.g., overdose deaths) - have risen substantively. Unfortunately, major knowledge gaps related to systematic monitoring of PO-related harms continue to exist; for example, no national morbidity or mortality statistics are available. Investigator-driven research has generated important insights into the epidemiology and impacts of PO-related harms: high correlations between population-level PO dispensing and/or PO dosing and harms; high rates of co-occurrence of NMPOU and co-morbidities; and distinct NMPOU-related risk dynamics among street drug users. Select policy measures have been implemented only recently at the federal and provincial levels; these interventions remain to be systematically evaluated, especially given preliminary indications of reductions in PO-related harms (e.g., NMPOU) unfolding prior to the interventions. For these purposes, improvements in surveillance tools and research resources devoted to the extensive public health problem of PO-related harms in Canada continue to be urgently needed.

SUBMITTER: Fischer B 

PROVIDER: S-EPMC6972194 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.

Fischer Benedikt B   Gooch Jenna J   Goldman Brian B   Kurdyak Paul P   Rehm Jürgen J  

Canadian journal of public health = Revue canadienne de sante publique 20140416 2


Five years ago, we highlighted Canada's emerging problem of prescription opioid (PO)-related harms and emphasized the need for targeted surveillance, research and interventions. Overall levels of PO use in the Canadian population have grown by 70% since then, while at the same time levels of non-medical PO use (NMPOU) in general and in key risk populations have continued to be high; furthermore, PO-related harms - specifically morbidity (e.g., treatment admissions) and mortality (e.g., overdose  ...[more]

Similar Datasets

| S-EPMC6647549 | biostudies-literature
| S-EPMC6774839 | biostudies-literature
| S-EPMC5555044 | biostudies-other
| S-EPMC7962340 | biostudies-literature
| S-EPMC8088205 | biostudies-literature
| S-EPMC5771131 | biostudies-literature
| S-EPMC5690609 | biostudies-literature
| S-EPMC9246186 | biostudies-literature
| S-EPMC5673257 | biostudies-literature
| S-EPMC4917790 | biostudies-literature